Centrally Acting ACE Inhibition in SLE

Clinical trial NCT04486118 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04486118
Sponsor: Northwell Health
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2021-10-01
Primary completion: 2025-06-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.